Doctor Teruki Sato
Akita University Graduate School of Medicine, Akita (Japan)
A novel APJ ligand, ELABELA/Apela/Toddler, protects from pressure overload- and Angiotensin II-induced cardiac hypertrophy and fibrosis
Event: ESC Congress 2017
Topic: Basic Science
Session: Remodelling and cardioprotection
ESC 365 is supported by
